top of page

RECARDIO

PRESS

Recardio at LSX World Congress USA

Recardio at LSX World Congress USA

Recardio at LSX World Congress USA

San Francisco, August 12, 2025 - Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular...

Aug 111 min read

Newly Granted Patent Application improves Patient Compliance

Newly Granted Patent Application improves Patient Compliance

Newly Granted Patent Application improves Patient Compliance

San Francisco, May 27, 2025 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular and...

May 272 min read

Recardio signs letter of intent with Kancera for licensing of cardiometabolic assets

Recardio signs letter of intent with Kancera for licensing of cardiometabolic assets

Recardio signs letter of intent with Kancera for licensing of cardiometabolic assets

San Francisco, March 7, 2025 - Recardio Inc., a late clinical-stage life science company developing therapies for cardiovascular and...

Mar 73 min read

bottom of page